Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness - PubMed (original) (raw)
Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness
Terhi Jokilehto et al. Clin Cancer Res. 2006.
Abstract
Purpose: Hypoxia in tumors is associated with poor prognosis and resistance to treatment. The outcome of hypoxia is largely regulated by the hypoxia-inducible factors (HIF-1alpha and HIF-2alpha). HIFs in turn are negatively regulated by a family of prolyl hydroxylases (PHD1-3). The PHD2 isoform is the main down-regulator of HIFs in normoxia and mild hypoxia. This study was designed to analyze the correlation of the expression and subcellular localization of PHD2 with the pathologic features of human carcinomas and HIF-1alpha expression.
Experimental design: The expression of PHD2 was studied from paraffin-embedded normal tissue (n = 21) and head and neck squamous cell carcinoma (HNSCC; n = 44) by immunohistochemistry. Further studies included PHD2 mRNA detection and HIF-1alpha immunohistochemistry from HNSCC specimens as well as PHD2 immunocytochemistry from HNSCC-derived cell lines.
Results: In noncancerous tissue, PHD2 is robustly expressed by endothelial cells. In epithelium, the basal proliferating layer also shows strong expression, whereas the more differentiated epithelium shows little or no PHD2 expression. In HNSCC, PHD2 shows strongly elevated expression both at the mRNA and protein level. Moreover, PHD2 expression increases in less differentiated phenotypes and partially relocalizes from the cytoplasm into the nucleus. Endogenously high nuclear PHD2 is seen in a subset of HNSCC-derived cell lines. Finally, although most of the tumor regions with high PHD2 expression show down-regulated HIF-1alpha, regions with simultaneous HIF-1alpha and PHD2 expression could be detected.
Conclusions: Our results show that increased levels and nuclear translocation of the cellular oxygen sensor, PHD2, are associated with less differentiated and strongly proliferating tumors. Furthermore, they imply that even the elevated PHD2 levels are not sufficient to down-regulate HIF-1alpha in some tumors.
Similar articles
- Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA, Lai SY, Ziober AF, Ziober BL. Cohen NA, et al. Laryngoscope. 2004 Mar;114(3):418-23. doi: 10.1097/00005537-200403000-00006. Laryngoscope. 2004. PMID: 15091212 - Retention of prolyl hydroxylase PHD2 in the cytoplasm prevents PHD2-induced anchorage-independent carcinoma cell growth.
Jokilehto T, Högel H, Heikkinen P, Rantanen K, Elenius K, Sundström J, Jaakkola PM. Jokilehto T, et al. Exp Cell Res. 2010 Apr 15;316(7):1169-78. doi: 10.1016/j.yexcr.2010.02.012. Epub 2010 Feb 12. Exp Cell Res. 2010. PMID: 20156434 - Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
Henze AT, Riedel J, Diem T, Wenner J, Flamme I, Pouyseggur J, Plate KH, Acker T. Henze AT, et al. Cancer Res. 2010 Jan 1;70(1):357-66. doi: 10.1158/0008-5472.CAN-09-1876. Epub 2009 Dec 22. Cancer Res. 2010. PMID: 20028863 - HIF-prolyl hydroxylases and cardiovascular diseases.
Sen Banerjee S, Thirunavukkarasu M, Tipu Rishi M, Sanchez JA, Maulik N, Maulik G. Sen Banerjee S, et al. Toxicol Mech Methods. 2012 Jun;22(5):347-58. doi: 10.3109/15376516.2012.673088. Toxicol Mech Methods. 2012. PMID: 22424133 Review. - Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D, Brown JM. Vordermark D, et al. Strahlenther Onkol. 2003 Dec;179(12):801-11. doi: 10.1007/s00066-003-1150-9. Strahlenther Onkol. 2003. PMID: 14652668 Review.
Cited by
- The Nuclear Export Inhibitor Selinexor Inhibits Hypoxia Signaling Pathways And 3D Spheroid Growth Of Cancer Cells.
Depping R, von Fallois M, Landesman Y, Kosyna FK. Depping R, et al. Onco Targets Ther. 2019 Oct 11;12:8387-8399. doi: 10.2147/OTT.S213208. eCollection 2019. Onco Targets Ther. 2019. PMID: 31632086 Free PMC article. - Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer.
Kozlova N, Wottawa M, Katschinski DM, Kristiansen G, Kietzmann T. Kozlova N, et al. Oncotarget. 2017 Feb 7;8(6):9885-9898. doi: 10.18632/oncotarget.14241. Oncotarget. 2017. PMID: 28038470 Free PMC article. - Factor-inhibiting HIF (FIH) promotes lung cancer progression.
García-Del Río A, Prieto-Fernández E, Egia-Mendikute L, Antoñana-Vildosola A, Jimenez-Lasheras B, Lee SY, Barreira-Manrique A, Zanetti SR, de Blas A, Velasco-Beltrán P, Bosch A, Aransay AM, Palazon A. García-Del Río A, et al. JCI Insight. 2023 Oct 23;8(20):e167394. doi: 10.1172/jci.insight.167394. JCI Insight. 2023. PMID: 37707961 Free PMC article. - Genome-Wide Interrogation of Human Cancers Identifies EGLN1 Dependency in Clear Cell Ovarian Cancers.
Price C, Gill S, Ho ZV, Davidson SM, Merkel E, McFarland JM, Leung L, Tang A, Kost-Alimova M, Tsherniak A, Jonas O, Vazquez F, Hahn WC. Price C, et al. Cancer Res. 2019 May 15;79(10):2564-2579. doi: 10.1158/0008-5472.CAN-18-2674. Epub 2019 Mar 21. Cancer Res. 2019. PMID: 30898838 Free PMC article. - Cellular characterization of ultrasound-stimulated microbubble radiation enhancement in a prostate cancer xenograft model.
Al-Mahrouki AA, Iradji S, Tran WT, Czarnota GJ. Al-Mahrouki AA, et al. Dis Model Mech. 2014 Mar;7(3):363-72. doi: 10.1242/dmm.012922. Epub 2014 Jan 30. Dis Model Mech. 2014. PMID: 24487407 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical